Drooid Logo
Back to today’s briefing

Story perspectives

Nighttime Dosing Shows Slight BP Benefits, Adherence Key

10/30/2025

32 6

1 of 1

Story summary
  • The OMAN trial found nighttime dosing lowered blood pressure more than morning dosing, but did not reduce cardiovascular events.
  • BedMed and TIME trials found no significant differences in outcomes between dosing times.
  • A TIME substudy suggested chronotype may influence treatment timing effects, but results were limited by low participant response rates.
  • Overall, nighttime dosing may offer slight benefits, but medication adherence remains crucial for effective blood pressure management.